Schering-Plough
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Schering-Plough
Go to Feed to see what's new!
+Feed
 
Wikipedia.org
Schering-Plough (Wikipedia.org)

Schering-Plough Corporation ( ) is a pharmaceutical company founded in 1851 by Ernst Schering as Schering AG in Germany. Following the entry of the United States into World War II in 1941, U.S. President Franklin Delano Roosevelt ordered Schering AG's U.S. assets be seized. These became Schering Corporation. The company was placed under a government administratorship until 1952, when it was released and its assets sold to the private sector. In 1971, the Schering Corporation merged with Plough to form Schering Plough.

Today Schering Plough manufactures several pharmaceutical drugs, the most well-known of which are the allergy drugs Claritin and Clarinex, and through a collaboration with Merck & Co., Vytorin, an anti-cholesterol drug.

Schering Plough also owns and operates the major foot care brand name Dr. Scholl's and the skin care line Coppertone.

As of June 2005, Schering Plough has 1.4% market share in the U.S., placing it at #17 in the top 20 pharmaceutical corporations by sales compiled by IMS Health.

One of their plants, in Upper Hutt, New Zealand is the largest single site for the production of veterinary vaccines in the world. This is largely due to the fact that New Zealand's isolation has formed a natural quarantine and is free of rabies, foot and mouth, scrapie, bovine spongiform encephalopathy and many other livestock diseases. It formerly had echinococcosis, but this has been eradicated. The site is known locally as "Coopers Animal Health," a trademark still in use by Schering Plough in Australia, but not elsewhere.

more...
Videos
Refine
Discussing the credit crunch and its impact at home and abroad, with Fred Hassan, Schering- Plough CEO and CNBC's Erin Burnett.
Yesterday
MSN Video
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Schering-Plough
Fred Hassan
Credit crunch
Erin Burnett
Go to Feed to see what's new!
share
keep
 
 
Massachusetts is another state having trouble raising cash, with Ken Volpert, Vanguard Funds and Tim Cahill, Massachusetts treasurer; Fred Hassan, Schering- Plough CEO; and CNBC's Erin Burnett.
Yesterday
MSN Video
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Tim Cahill
Schering-Plough
Fred Hassan
U.S. state
Erin Burnett
Go to Feed to see what's new!
share
keep
 
 
409
New questions arise about the safety and efficacy of Merck and Schering-Plough's Vytorin, with CNBC's Mike Huckman
a month ago
MSN Video
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ezetimibesimvastatin
Schering-Plough
Go to Feed to see what's new!
share
keep
 
 
OSS - Organon in Oss wordt afgesplitst van Akzo Nobel. Organon wordt samengevoegd met diergeneesmiddelenproducent Intervet onder de naam Organon Biosciences. Dat bedrijf gaat als zelfstandige ...
a month ago
Omroep Brabant (Netherland)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Akzo Nobel
Schering-Plough
Go to Feed to see what's new!
share
keep
 
 
OSS - Bij geneesmiddelenfabrikant Organon in Oss verdwijnen tweehonderd banen. Door de overname door Schering-Plough zijn er veel dubbele functies die nu dus worden gesaneerd.Het betreft vooral ...
a month ago
Omroep Brabant (Netherland)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Schering-Plough
Go to Feed to see what's new!
share
keep
 
 
Cramer: Schering-Plough Unfairly Punished
2 months ago
The Street
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Schering-Plough
Jim Cramer
Go to Feed to see what's new!
share
keep
 
 
156
Schering-Plough beat Q2 expectations, reports CNBC's Mike Huckman
2 months ago
MSN Video
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Schering-Plough
Go to Feed to see what's new!
share
keep
 
 
222
The word cancer being mentioned in the same breath as a cholesterol-lowering drug has investors in Merck and Schering-Plough running for the exit. CNBC's Mike Huckman has the details.
2 months ago
MSN Video
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Schering-Plough
Go to Feed to see what's new!
share
keep